Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2017-03-21 05:18:59 UTC |
---|
Update Date | 2023-02-21 17:30:49 UTC |
---|
HMDB ID | HMDB0062347 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | 3,5-dihydroxy-3,4-dihydro-1,4-benzothiazine |
---|
Description | 3,5-dihydroxy-3,4-dihydro-1,4-benzothiazine is classified as a member of the Benzothiazines. Benzothiazines are organic compounds containing a benzene fused to a thiazine ring (a six-membered ring with four carbon atoms, one nitrogen atom and one sulfur atom). 3,5-dihydroxy-3,4-dihydro-1,4-benzothiazine is considered to be slightly soluble (in water) and basic |
---|
Structure | InChI=1S/C8H7NS/c1-2-4-8-7(3-1)9-5-6-10-8/h1-6,9H |
---|
Synonyms | Not Available |
---|
Chemical Formula | C8H7NS |
---|
Average Molecular Weight | 149.21 |
---|
Monoisotopic Molecular Weight | 149.029920403 |
---|
IUPAC Name | 4H-1,4-benzothiazine |
---|
Traditional Name | 4H-1,4-benzothiazine |
---|
CAS Registry Number | Not Available |
---|
SMILES | N1C=CSC2=CC=CC=C12 |
---|
InChI Identifier | InChI=1S/C8H7NS/c1-2-4-8-7(3-1)9-5-6-10-8/h1-6,9H |
---|
InChI Key | ZLILRRGWBOKBIG-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as benzothiazines. These are organic compounds containing a benzene fused to a thiazine ring (a six-membered ring with four carbon atoms, one nitrogen atom and one sulfur atom). |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Benzothiazines |
---|
Sub Class | Not Available |
---|
Direct Parent | Benzothiazines |
---|
Alternative Parents | |
---|
Substituents | - Benzothiazine
- Aryl thioether
- Benzenoid
- Para-thiazine
- Thioenolether
- Azacycle
- Enamine
- Organic nitrogen compound
- Hydrocarbon derivative
- Organonitrogen compound
- Amine
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 3.31 g/l | ALOGPS | LogP | 1.95 | ALOGPS |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times UnderivatizedChromatographic Method | Retention Time | Reference |
---|
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm √ó 2.1 mm; 1.7 Œºmparticle diameter). Predicted by Afia on May 17, 2022. | 4.25 minutes | 32390414 | Predicted by Siyang on May 30, 2022 | 11.196 minutes | 33406817 | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.3 minutes | 32390414 | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1360.2 seconds | 40023050 | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 401.4 seconds | 40023050 | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 115.0 seconds | 40023050 | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 244.6 seconds | 40023050 | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 88.3 seconds | 40023050 | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 347.3 seconds | 40023050 | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 312.4 seconds | 40023050 | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 233.9 seconds | 40023050 | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 889.8 seconds | 40023050 | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 300.5 seconds | 40023050 | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 947.6 seconds | 40023050 | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 288.2 seconds | 40023050 | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 319.6 seconds | 40023050 | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 457.8 seconds | 40023050 | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 289.7 seconds | 40023050 | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 177.0 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
3,5-dihydroxy-3,4-dihydro-1,4-benzothiazine,1TMS,isomer #1 | C[Si](C)(C)N1C=CSC2=CC=CC=C21 | 1623.0 | Semi standard non polar | 33892256 | 3,5-dihydroxy-3,4-dihydro-1,4-benzothiazine,1TMS,isomer #1 | C[Si](C)(C)N1C=CSC2=CC=CC=C21 | 1598.5 | Standard non polar | 33892256 | 3,5-dihydroxy-3,4-dihydro-1,4-benzothiazine,1TMS,isomer #1 | C[Si](C)(C)N1C=CSC2=CC=CC=C21 | 2149.0 | Standard polar | 33892256 | 3,5-dihydroxy-3,4-dihydro-1,4-benzothiazine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C=CSC2=CC=CC=C21 | 1850.3 | Semi standard non polar | 33892256 | 3,5-dihydroxy-3,4-dihydro-1,4-benzothiazine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C=CSC2=CC=CC=C21 | 1837.6 | Standard non polar | 33892256 | 3,5-dihydroxy-3,4-dihydro-1,4-benzothiazine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C=CSC2=CC=CC=C21 | 2348.4 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - 3,5-dihydroxy-3,4-dihydro-1,4-benzothiazine GC-MS (Non-derivatized) - 70eV, Positive | splash10-006t-1900000000-b02bb602d058432a873b | 2017-09-20 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3,5-dihydroxy-3,4-dihydro-1,4-benzothiazine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3,5-dihydroxy-3,4-dihydro-1,4-benzothiazine 10V, Positive-QTOF | splash10-0udi-0900000000-5ad676bce0be1ec8fe9f | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3,5-dihydroxy-3,4-dihydro-1,4-benzothiazine 20V, Positive-QTOF | splash10-0udi-0900000000-edc214e06f9c248f8cb4 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3,5-dihydroxy-3,4-dihydro-1,4-benzothiazine 40V, Positive-QTOF | splash10-001i-5900000000-3bb36ebf373c9d95a052 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3,5-dihydroxy-3,4-dihydro-1,4-benzothiazine 10V, Negative-QTOF | splash10-0002-0900000000-08701d77e8374cd01a3b | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3,5-dihydroxy-3,4-dihydro-1,4-benzothiazine 20V, Negative-QTOF | splash10-0002-0900000000-db3de1fbc96b6d815400 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3,5-dihydroxy-3,4-dihydro-1,4-benzothiazine 40V, Negative-QTOF | splash10-00di-1900000000-85caaf8a072625187496 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3,5-dihydroxy-3,4-dihydro-1,4-benzothiazine 10V, Negative-QTOF | splash10-0002-0900000000-3562640e821f8add3ef4 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3,5-dihydroxy-3,4-dihydro-1,4-benzothiazine 20V, Negative-QTOF | splash10-0002-0900000000-3562640e821f8add3ef4 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3,5-dihydroxy-3,4-dihydro-1,4-benzothiazine 40V, Negative-QTOF | splash10-0002-0900000000-a72f4e66d7dd72a88eec | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3,5-dihydroxy-3,4-dihydro-1,4-benzothiazine 10V, Positive-QTOF | splash10-0udi-0900000000-a41eaf40cec954bac8eb | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3,5-dihydroxy-3,4-dihydro-1,4-benzothiazine 20V, Positive-QTOF | splash10-0udi-0900000000-07ffa09bc9e72a8a7f2e | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3,5-dihydroxy-3,4-dihydro-1,4-benzothiazine 40V, Positive-QTOF | splash10-0udj-3900000000-1242b0d23b03beac7e2b | 2021-09-23 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-04 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-04 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-04 | FELIX lab | View Spectrum |
|
---|